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Abstract
Background
Early recognition of dengue, particularly patients at risk for plasma leakage, is important to
clinical management. The objective of this study was to build predictive models for dengue,
dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS) using structural
equation modelling (SEM), a statistical method that evaluates mechanistic pathways.
Methods/Findings
We performed SEM using data from 257 Thai children enrolled within 72 h of febrile illness
onset, 156 with dengue and 101 with non-dengue febrile illnesses. Models for dengue, DHF,
and DSS were developed based on data obtained three and one day(s) prior to fever resolu-
tion (fever days -3 and -1, respectively). Models were validated using data from 897 subjects
who were not used for model development. Predictors for dengue and DSS included age,
tourniquet test, aspartate aminotransferase, and white blood cell, % lymphocytes, and plate-
let counts. Predictors for DHF included age, aspartate aminotransferase, hematocrit, tourni-
quet test, and white blood cell and platelet counts. The models showed good predictive
performances in the validation set, with area under the receiver operating characteristic
curves (AUC) at fever day -3 of 0.84, 0.67, and 0.70 for prediction of dengue, DHF, and
DSS, respectively. Predictive performance was comparable using data based on the timing
relative to enrollment or illness onset, and improved closer to the critical phase (AUC 0.73 to
0.94, 0.61 to 0.93, and 0.70 to 0.96 for dengue, DHF, and DSS, respectively).
Conclusions
Predictive models developed using SEM have potential use in guiding clinical management
of suspected dengue prior to the critical phase of illness.
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Author summary
Dengue virus infection is one of the most critical public health issues, particularly in tropi-
cal and subtropical regions. This study developed statistical predictive models using the
data obtained from 257 Thai children for dengue, dengue hemorrhagic fever, and dengue
shock syndrome using structural equation modelling (SEM). We performed SEM based
on clinical and laboratory factors on three and one day(s) prior to fever resolution. Our
SEM models showed that age, tourniquet test, aspartate aminotransferase, and white
blood cell, % lymphocytes, and platelet counts on three days prior to fever resolution were
important risk factors for dengue and dengue hemorrhagic fever. Age, aspartate amino-
transferase, hematocrit, tourniquet test, and white blood cell and platelet counts were
important risk factors for dengue shock syndrome. Our predictive models showed good
performances in the validation subjects (n = 897) who were not used for SEM, and thus
we concluded that our predictive models can be practically used to guide clinical manage-
ment of suspected dengue patients. Our study also showed that SEM can be used to pre-
dict the developments or severities of other illnesses.
Introduction
Dengue virus (DENV) infection is a major public health issue worldwide particularly in tropi-
cal and subtropical regions. An estimated 390 million new DENV infections and 90 million
cases of dengue illnesses are estimated to occur in more than 100 endemic countries, resulting
in 20,000 deaths annually [1, 2]. In the past 50 years, the incidence of dengue has increased
30-fold [1, 3, 4].
DENV infection may result in a wide spectrum of disease severity ranging from asymptom-
atic infection to dengue fever (DF) and dengue hemorrhagic fever (DHF) [5]. DHF is charac-
terized by fever, plasma leakage, bleeding diathesis, and thrombocytopenia, that in severe cases
leads to shock (dengue shock syndrome, DSS) [5]. The mortality rate of DSS, up to 20% [6], is
substantially reduced by timely replacement of intravascular fluid and blood losses, highlight-
ing the importance of timely diagnosis of dengue, DHF, and DSS.
Several studies have developed diagnostic tools to predict the severity of an acute dengue ill-
ness [7–13]. Potts et al. developed predictive models using logistic regression analysis based on
maximum or minimum levels of clinical laboratory variables during the illness [7] and classifica-
tion and regression tree (CART) analysis based on clinical laboratory data on the day of presenta-
tion [8]. Chadwick et al. used logistic regression models based on clinical laboratory data within
the first 2 days of presentation [9]. Brasier et al. used both logistic regression and a classification
and regression tree analyses based on laboratory data on the day of presentation [10]. Recently,
Nguyen et al. used logistic regression models based on laboratory data and nonstructural protein
1 rapid antigen testing on the day of presentation within72 hours of fever [12]. These model-
ing approaches do not consider the underlying mechanisms of illness, are likely to overlook pre-
dictors for which opposite, indirect effects may offset one another, and cannot consider the
relationship among covariates longitudinally. Predictive models which attempt to capture under-
lying mechanistic pathways might be a more biologically reliable and robust approach.
Progression of acute dengue illness is characterized by interdependent clinical and labora-
tory factors which change over the course of illness. Predictive models developed using struc-
tural equation model (SEM) have an advantage over models developed by general regression
analysis because SEM can determine interdependent relationships among predictors and how
they impact outcomes [14]. No studies have been performed to apply SEM approaches to
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predict dengue illness severity. The objective of this study was to construct statistical predictive
models for dengue, DHF, and DSS by developing a series of SEMs.
Methods
Study setting
Data are from a longitudinal observational investigation at two hospitals in Thailand. Detailed
descriptions of this investigation are provided elsewhere [7, 8]. Briefly, 1,384 children between 6
months and 15 years of age who presented with temperature of at least 38.5˚C for less than 72
hours without any other identified source of infection were enrolled at Queen Sirikit National
Institute of Child Health (QSNICH) in 1994–1997 (n = 506), 1999–2002 (n = 347), and 2004–
2007 (n = 337) and the Kamphaeng Phet Provincial Hospital (KPPPH) in 1994–1997 (n = 194).
Mean ages of each cohort were 8.9, 6.9, 7.8, and 8.9 years, respectively. In each cohort, 67.6%
(DHF = 31.2%, DSS = 4.1%), 43.0% (DHF = 18.6%, DSS = 3.3%), 39.7% (DHF = 12.4%, DSS =
2.7%), and 61.4% (DHF = 18.3%, DSS = 3.8%) were diagnosed as having dengue, respectively.
Most subjects were enrolled from the outpatient clinic. Each child was hospitalized per protocol
and monitored in hospital until clinically stable and at least 1 day after defervescence. Children
who had signs of shock at the first visit, chronic disease, or an initial alternate non-dengue diag-
nosis were excluded. All participants’ parents provided written informed consent prior to enroll-
ment. This study followed the Ethical Principles for Medical Research Involving Human
Subjects as defined by the Declaration of Helsinki and was approved by the Institutional Review
Boards of the Ministry of Public Health (numbers: 102/2546, 71/2552, and 104/2552), Thailand,
the US Army (numbers of Walter Reed Army Institute of Research: 436, 436b, and 1077/1620),
and the University of Massachusetts Medical School (number: H-2222). Material has been
reviewed by the Walter Reed Army Institute of Research. There is no objection to its presenta-
tion and/or publication. The opinions or assertions contained herein are the private views of the
author, and are not to be construed as official, or as reflecting true views of the Department of
the Army, the Department of Defense, or the National Institutes of Health. The investigators
have adhered to the policies for protection of human subjects as prescribed in AR 70–25.
Definitions
Fever day 0 was defined as the day of defervescence, when the temperature was less than 38˚C
for a consecutive 12 hours; days before and after defervescence were numbered consecutively.
Study day 1 was defined as the day a child was enrolled in the study. Illness day 1 was defined
as the day of onset of symptoms. Subjects (or their parent/guardian) were asked to identify the
date of onset of their illness. This usually was the date of onset of fever.
Based on review of the medical records including study laboratory tests (see below), a physi-
cian who was not involved in patient care assigned a final clinical diagnosis as DF or DHF
grade I to IV, guided by the 1997 World Health Organization guidelines [5].
Laboratory testing
A venous blood specimen was collected daily. Plasma samples were tested for levels of aspar-
tate aminotransferase (AST), alanine aminotransferase (ALT), and albumin using a Clinical
System Analyzer (model 700; Beckmann Instruments, Brea, CA). Total white blood cell
(WBC) count, platelet count, and hematocrit values were determined using a T540 hemato-
logic analyzer (Coulter Electronics, Hialeah, FL). A tourniquet test was performed with the
right and left arms alternately each day and the number of petechiae within a 1 sq in template
(up to 20) was recorded; daily testing was stopped if the maximum value of 20 petechiae was
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recorded. Dengue was confirmed by viral isolation by mosquito inoculation and/or detection
of viral RNA by reverse transcription polymerase chain reaction in plasma, and/or by serologi-
cal assays (immunoglobulin M/G enzyme-linked immunosorbent assay and hemagglutination
inhibition assay) of paired acute-convalescent plasma samples as described [15].
Statistical analysis
Our statistical analysis focused on the predictive value of clinical and laboratory data that are
well validated for testing in typical clinical settings: tourniquet test, AST, ALT, albumin, WBC
count, WBC differential, hematocrit, and platelet count. Outcomes of interest (dengue, DHF,
or DSS) were defined as occurring at fever day +1, the final day of data collection and the day
that a decubitus chest X-ray was performed to detect plasma leakage. To develop the predictive
models, we used data from children who had all these variables obtained two and four days
earlier (i.e., on fever days -3 and -1). There was a large amount of missing data on fever day -3
or -1 (totally 79.3%, ranging from 19.1% to 71.0% across variables) in 1,244 subjects who had a
diagnosis of dengue or other non-dengue febrile illness and any laboratory data between fever
day -3 and +1 (Fig 1). We therefore determined to perform complete analyses to build SEMs
using the data from 257 subjects who had the complete data of predictors on fever day -3 or -1.
To assess the sensitivity of our SEMs to missing data, we then employed multiple imputation
for the full 1,244 subjects. We performed the Markov-chain Monte Carlo method to create 50
imputed data sets with no missing data. The results were pooled across the complete datasets.
SEMs were built using Mplus 8 statistical software (Muthe´n and Muthe´n 1998–2017). SEM
parameters were estimated using the weighted least squares means and variances adjusted esti-
mator with the theta parameterization. SEMs for dengue, DHF, and DSS were constructed
based on the hypothesized mechanisms (Fig 2A). The minimum sample size for our SEMs was
estimated as 207, together with degree of freedom of 66, significance level of 0.05, and desired
statistical power of 0.80, on the basis of model-fitting with the root mean square error of
approximation (RMSEA) [16, 17]. Our subjects for developing the predictive models exceeded
the minimum required to achieve the desired power level. Significant predictors were retained
in the final SEMs. AST, ALT, WBC count, hematocrit, platelet count, and tourniquet test were
natural log-transformed after adding integer 1 to improve the distribution and homogeneity of
variance. RMSEA below 0.07 and the comparative fit index (CFI) that exceed 0.95 indicate
good model fit [18]. However, we did not use the criterion for the χ2 test, because the χ2 test is
very sensitive to the large sample size [19]. In the sensitivity analyses using multiple imputa-
tion, we used the same criteria of RMSEA and CFI.
SEMs were used to develop the predictive models (see S1 Supporting Information). To
achieve the earliest prediction, we used total effects of significant predictors at fever day -3 on
the outcome of interest diagnosed at fever day +1. The performance of predictive models was
examined by the receiver operating characteristic (ROC) curves and the area under the curves
(AUCs) of the dataset acquired from 897 children who were not used to develop models in this
study. The sensitivity (Se), specificity (Sp), positive predictive value (PPV), and negative pre-
dictive value (NPV) at the Youden index-based optimal cut-offs were calculated. Statistical
analysis was performed using SAS 9.4 statistical software (SAS Institute, Cary, NC, USA), with
exception of SEM. A P value < 0.05 was considered to be statistically significant. All data were
anonymously analyzed.
Results
Of the 257 children used to develop SEMs; 60.7% (n = 156), 19.8% (n = 51), and 3.5% (n = 9)
of these children were diagnosed as dengue, DHF, and DSS, respectively. At fever days -3 and
A structural equation model for dengue
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-1, AST, ALT, WBC count, hematocrit, platelet count, and tourniquet test were significantly
different between groups (non-dengue, dengue but non-DHF, DHF but non-DSS, and DSS,
Table 1). Pearson correlation coefficients among predictors and outcomes are presented in S2
Fig 1. Study participants.
https://doi.org/10.1371/journal.pntd.0006799.g001
A structural equation model for dengue
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Supporting Information. Children who were used to develop SEMs (n = 257) were not signifi-
cantly different from those used for validation of SEM-based predictive models (n = 897) with
respect to age (8.1 vs. 7.8 years), sex (48.3 vs. 43.6% girls), and the proportions of cases with
DHF [17.3% (n = 155) for the validation set] and DSS [3.2% (n = 29) for the validation set] (P
values of t-test or χ2 test>0.05). Moreover, the characteristics of 257 children used to develop
SEMs were not significantly different from the 987 (= 1,244–257) children who had a diagnosis
of dengue or non-dengue febrile illness and any laboratory data between fever day -3 and +1
but were not used to develop SEMs, in terms of age, sex, and the proportions of cases with
DHF and DSS (P values of t-test or χ2 test >0.05). A higher percentage of subjects in the
Fig 2. (A) Hypothesized pathways for developing dengue, DHF, or DSS and structural equation models predicting (B) dengue, (C) DHF, and (D) DSS. (B) The
model fits were RMSEA = 0.057 and CFI = 0.979. (C) The model fits were RMSEA = 0.000 and CFI = 1.000. (D) The model fits were RMSEA = 0.095 and CFI = 0.937.
Arrows indicate hypothetically significant positive or negative associations in (A). Solid and dotted arrows indicate significant positive and negative associations,
respectively, in (B), (C), and (D). Unstandardized (= B) and standardized (= β) coefficients are shown next to the arrows. Correlations were omitted from the diagram.
Unit: age, y; AST, U/mL; ALT, U/mL; WBC, cells/mm3; Lymphocytes, %; Albumin, g/dL; Hematocrit, %; Platelets, cells/mm3; Tourniquet test, petechiae/in2. AST,
ALT, WBC, hematocrit, platelets, and tourniquet test were ln-transformed. Thickness of arrows was determined by standardized coefficients. P value<0.05, P
value<0.01, P value<0.001.
https://doi.org/10.1371/journal.pntd.0006799.g002
A structural equation model for dengue
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validation set were enrolled at KPPPH (8.6 vs. 13.5% for developing and validation sets, respec-
tively; P value of χ2 test = 0.035).
The SEM for any dengue illness included age, AST, WBC count, % lymphocytes, platelet
count, and tourniquet test at fever day -3 and AST, WBC count, and tourniquet test at fever
day -1 (Fig 2B). AST, WBC count, and tourniquet test at fever day -3 were strongly predictive
of their corresponding values at fever day -1. In addition, WBC and platelet counts were nega-
tive predictors of AST at fever day -1 and % lymphocytes was a positive predictor of WBC
count at fever day -1. Taking both direct and indirect effects into account in SEM, the total
effects of age, AST, and tourniquet test at fever day -3 were significantly related to an increased
risk of any dengue illness, while WBC count, % lymphocytes, and platelet count were inversely
related to risk of any dengue illness (Table 2).
The SEM for DHF included age, AST, WBC count, hematocrit, platelet count, and tourniquet
test at fever day -3 and AST, hematocrit, platelet count, and tourniquet test at fever day -1 (Fig
2C). AST, hematocrit, platelet count, and tourniquet test at fever day -3 were strongly correlated
with their corresponding values at fever day -1. In addition, WBC count and platelet count were
negative predictors of AST at fever day -1 and WBC count was a positive predictor of platelet
count at fever day -1. Taking both direct and indirect effects into account, the total effects of age,
AST, hematocrit, and tourniquet test at fever day -3 were related to increased risk of DHF at fever
day +1, while WBC and platelet counts were inversely related to risk of DHF (Table 2).
The SEM for DSS included age, AST, WBC count, % lymphocytes, platelet count, and tour-
niquet test at fever day -3 and AST, WBC count, and platelet count at fever day -1 (Fig 2D).
Table 1. Characteristics of study participants (n = 257).
Non-dengue Dengue,
non-DHF
DHF,
non-DSS
DSS P value
n 101 (39.3%) 105 (40.9%) 42 (16.3%) 9 (3.5%)
Sex (= girl) 51 (50.5%) 51 (48.6%) 14 (33.3%) 8 (88.9%) 0.018
Age, yr 6.8 (6.2–7.3) 8.9 (8.4–9.5)b 9.3 (8.3–10.4)b 8.5 (6.1–10.9) <0.001
At fever day -3
AST, U/mLa 35.8 (33.4–38.3) 45.9 (42.0–50.3)b 47.7 (39.8–57.2)b 65.7 (33.5–128.1)b <0.001
ALT, U/mLa 18.6 (17.2–20.1) 23.0 (20.6–25.7)b 23.3 (18.9–28.7) 31.7 (15.4–64.4)b 0.003
WBC, 1,000 cells/mm3,a 7.4 (6.7–8.2) 4.2 (3.8–4.5)b 4.0 (3.4–4.6)b 4.2 (2.9–6.1)b <0.001
Lymphocytes, % 27.1 (23.5–30.7) 24.3 (21.6–27.0) 23.6 (17.9–29.4) 24.6 (9.3–39.8) 0.57
Albumin, g/dL 4.6 (4.6–4.7) 4.7 (4.6–4.8) 4.8 (4.6–4.9) 4.4 (4.1–4.8) 0.33
Hematocrit, %a 38.3 (37.7–38.8) 38.9 (38.3–39.5) 39.8 (38.8–40.8)b 37.4 (34.8–40.2) 0.031
Platelets, 1,000 cells/mm3,a 228 (212–244) 190 (176–206)b 167 (136–205)b 158 (114–219) <0.001
Tourniquet test, petechiae/in2,a 4.6 (3.6–5.8) 6.4 (5.1–7.9) 9.9 (7.4–13.1)b 8.4 (4.9–13.9) 0.002
At fever day -1
AST, U/mLa 37.6 (33.8–41.7) 70.2 (61.4–80.2)b 95.1 (76.4–118.3)b,c 137.5 (75.2–250.8)b,c <0.001
ALT, U/mLa 19.1 (17.3–21.1) 33.5 (29.0–38.7)b 38.9 (30.5–49.4)b 60.6 (23.8–152.0)b <0.001
WBC, 1,000 cells/mm3,a 5.3 (4.9–5.9) 2.7 (2.5–2.9)b 2.7 (2.4–3.1)b 4.3 (2.8–6.5)c,d <0.001
Lymphocytes, % 38.7 (35.2–42.1) 38.7 (36.3–41.2) 33.5 (29.2–37.7) 35.9 (23.8–48.0) 0.23
Albumin, g/dL 4.4 (4.4–4.5) 4.4 (4.3–4.5) 4.4 (4.2–4.6) 4.0 (3.4–4.5)b 0.06
Hematocrit, %a 37.3 (36.6–38.1) 38.4 (37.7–39.2) 40.6 (39.3–41.8)b,c 42.0 (38.1–46.3)b <0.001
Platelets, 1,000 cells/mm3,a 206 (190–223) 140 (128–153)b 110 (93–131)b,c 69 (40–118)b,c,d <0.001
Tourniquet test, petechiae/in2,a 3.3 (2.4–4.3) 8.4 (6.7–10.5)b 12.2 (9.6–15.4)b 18.9 (16.2–22.1)b <0.001
Data represent arithmetic or geometrica mean (95% confidence interval) or n (proportion, %). b, c, and d Significantly different from non-dengue, dengue but non-DHF,
and DHF but non-DSS, respectively, P value <0.05. P values were estimated by Fisher’s exact tests or analysis of variance followed by Bonferroni post hoc test.
https://doi.org/10.1371/journal.pntd.0006799.t001
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AST, WBC count, and platelet count at fever day -3 were strongly predictive of their corre-
sponding values at fever day -1. In addition, WBC and platelet counts were negative predictors
of AST at fever day -1, AST was a positive predictor of WBC count at fever day -1, and WBC
count was a positive predictor of platelet count at fever day -1. Taking both direct and indirect
effects into account, the total effect of AST at fever day -3 was positively significant in diagnosis
of DSS at fever day +1, but that of platelet count was negatively significant (Table 2).
For all three SEMs, fever day -1 parameters were predicted by fever day -3 parameters (see
S3 Supporting Information). Therefore, we reasoned that data from a single time point might
be sufficient for prediction of outcome. Using the regression coefficients for fever day -1 data,
we derived revised SEM equations for dengue (vs. non-dengue illness), DHF (vs. all other diag-
noses) and DSS (vs. all other diagnoses). The equations are available in S4 Supporting Informa-
tion. The raw data used for SEM is available in S5 Supporting Information. We tested the
predictive model over a range of fever days from -3 to 0; AUCs of the predictive model for den-
gue were in the range of 0.84 to 0.94 (Fig 3A). AUCs of the predictive model for DHF were in
the range of 0.67 to 0.93 over fever days -3 to 0 (Fig 3B). Finally, AUCs of the predictive model
for DSS were in the range of 0.70 to 0.96 over fever days -3 to 0 (Fig 3C). The proposed SEMs
for dengue and DHF demonstrated good fit of the data, while the model for DSS demonstrated
adequate fit of the data (Fig 2). In the sensitivity analyses using multiple imputations for miss-
ing values, our SEMs did not show good fits, but it was acceptable (RMSEA: 0.080 to 0.119,
CFI: 0.896 to 0.953).
Although the SEMs performed well over a range of fever day values, this parameter is
defined retrospectively; therefore, we sought to further assess the performance of these models
Table 2. Total effect of predictors at fever day -3 in developing dengue, DHF, and DSS based on SEMs.
Outcome Predictor Unstandardized coefficient (= B) Standardized coefficient (= β) Odds ratio (95% confidence interval) P value
Dengue
Age, y 0.298 0.140 1.35 (1.20–1.52) <0.001
AST, U/mL 1.191 0.265 3.29 (2.30–4.70) <0.001
WBC, cells/mm3 -1.422 -0.378 0.24 (0.14–0.42) <0.001
Lymphocytes, % -0.009 -0.067 0.991 (0.983–0.999) 0.034
Platelets, cells/mm3 -0.199 -0.042 0.82 (0.72–0.93) 0.002
Tourniquet test, petechiae/in2 0.271 0.117 1.31 (1.07–1.60) 0.008
DHF
Age, y 0.110 0.079 1.12 (1.06–1.18) <0.001
AST, U/mL 0.380 0.129 1.46 (1.10–1.94) 0.008
WBC, cells/mm3 -0.352 -0.135 0.70 (0.58–0.85) <0.001
Hematocrit, % 2.453 0.138 11.62 (2.11–64.08) 0.005
Platelets, cells/mm3 -0.289 -0.092 0.75 (0.63–0.89) 0.001
Tourniquet test, petechiae/in2 0.305 0.205 1.36 (1.10–1.67) 0.004
DSS
Age, y -0.012 -0.009 0.99 (0.95–1.03) 0.52
AST, U/mL 0.652 0.237 1.92 (1.07–3.44) 0.028
WBC, cells/mm3 0.339 0.139 1.40 (0.80–2.45) 0.23
Lymphocytes, % 0.007 0.087 1.007 (0.999–1.015) 0.11
Platelets, cells/mm3 -0.527 -0.184 0.59 (0.42–0.83) 0.003
Tourniquet test, petechiae/in2 -0.081 -0.063 0.92 (0.84–1.01) 0.08
Total effect was the sum of direct and indirect effects. AST, WBC, hematocrit, platelets, and tourniquet test were ln-transformed. AST, ALT, WBC, hematocrit, platelets,
and tourniquet test were ln-transformed.
https://doi.org/10.1371/journal.pntd.0006799.t002
A structural equation model for dengue
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under typical clinical scenarios, by testing the models based on study day (time relative to pre-
sentation for medical care) and illness day (time relative to illness onset). AUCs of the predic-
tive model for dengue were in the range of 0.88 to 0.92 and 0.73 to 0.94 for study days 1 to 3
(Fig 4A) and illness days 2 to 5 (Fig 5A), respectively. AUCs of the predictive model for DHF
were in the range of 0.81 to 0.91 and 0.61 to 0.87 for study days 1 to 3 (Fig 4B) and illness days
Fig 3. ROC curves for external validation employing fever days: (A) dengue, (B) DHF, and (C) DSS. n = 878 (nfever day -3 = 143, nfever day -2 = 366, nfever day -1 =
590, and nfever day 0 = 617).
https://doi.org/10.1371/journal.pntd.0006799.g003
Fig 4. ROC curves for external validation employing study days: (A) dengue, (B) DHF, and (C) DSS. n = 896 (nstudy day 1 = 880, nstudy day 2 = 579, and nstudy day 3
= 318).
https://doi.org/10.1371/journal.pntd.0006799.g004
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2 to 5 (Fig 5B), respectively. AUCs of the predictive model for DSS were in the range of 0.76 to
0.92 and 0.74 to 0.86 for study days 1 to 3 (Fig 4C) and illness days 2 to 5 (Fig 5C), respectively.
Discussion
We sought to develop predictive models to determine the probability of dengue, DHF, or DSS
based on clinical and laboratory data available prior to the critical phase of illness which typi-
cally occurs within 24 hours of defervescence. We used SEMs to impose a hypothetical struc-
ture on the associations between these parameters. This approach allowed us to identify
predictors at a single time point as early as fever day -3 which could predict the progression of
disease. We further demonstrated that the SEM equations performed well using data from a
wide range of time points during illness. The predictive accuracy of the SEMs improved using
data collected at later time points, consistent with the progression of clinical and laboratory
abnormalities in dengue.
Our SEMs identified elevated AST levels and decreased platelet count as significant predic-
tors of all three outcomes of dengue, DHF, and DSS (Table 2). Previous studies observed that
AST and ALT are commonly elevated in dengue and correlate with the severity of illness [15,
20, 21]. In our study, because these biomarkers were highly correlated (e.g., Pearson r at illness
day -3 = 0.76), only AST remained in the SEMs. Our findings of an inverse relationship
between platelet count and risk of dengue illness are also consistent with previous studies [7, 8,
12, 22, 23]. Decreased platelet count might be mechanistically linked to plasma leakage
through its effects on vascular barrier function [24–26].
In the present study, older age, decreased WBC count, and increased number of petechiae
in a tourniquet test were common significant risk factors for dengue and DHF. Although a
meta-analysis reported an increased risk of DSS in younger children [23], which was attributed
to their more permeable and fragile microvasculature [27], other studies reported contrasting
findings [28]. These inconsistent results may be due to the differences in approaches to
Fig 5. ROC curves for external validation employing illness days: (A) dengue, (B) DHF, and (C) DSS. n = 885 (nillness day 2 = 267, nillness day 3 = 481, nillness day 4 =
572, and nillness day 5 = 377).
https://doi.org/10.1371/journal.pntd.0006799.g005
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adjustment for potential confounders in statistical models. Indeed, several studies showed a
significant association of severe dengue with age in univariable analyses but not in multivari-
able analyses [7, 12]. Although decreased WBC count was significantly associated with
increased risks for dengue and DHF, this association was not significant for DSS. Both leuko-
penia and leukocytosis have been described in dengue, depending on the timing during illness
[11, 29, 30]. Our findings for the tourniquet test were consistent with other studies which
showed a crucial role for this clinical parameter in predictive models for acute dengue illnesses
[7, 15, 31].
A novel aspect of SEM is the ability to identify correlations between factors contributing to
prediction of the final outcome, which implies a mechanistic relationship. For example, all
three models showed negative associations between WBC and platelet counts at fever day -3
and AST at fever day -1, and the models for DHF and DSS showed positive associations
between WBC count at fever day -3 and platelet count at fever day -1. The positive association
between WBC and platelet counts can potentially be explained by common mechanisms such
as bone marrow suppression [30]. The negative association of WBC and platelet counts with
AST is less clear, and may point to other mechanistic pathways such as immune activation
[32].
Our predictive models showed good performance for identifying children who progressed
to dengue, DHF, and DSS. We provided Se, Sp, PPV, and NPV at the Youden index-based
optimal cut-offs, however, cut-off points may need to be modified depending on the objectives:
for example, to increase Se for detecting a lethal condition. To capture all DSS cases using our
SEM model with data from study day 3, it would be necessary to use a cut-off of 0.0172, with
correspondingly lower Sp (55.3%) and PPV (10.6%) (Fig 5C).
Our study followed the case classification of DF, DHF, and DSS in use during the study
period (and still in use in QSNICH and some other countries) rather than the alternative clas-
sification of dengue and severe dengue published in 2009 [33]. Our DSS cases correspond to
severe dengue as defined in 2009, as there were no cases in our study with significant respira-
tory distress, clinically significant bleeding, or significant organ dysfunction. We did not col-
lect data specifically for identification of cases as dengue with warning signs as defined in the
2009 classification.
To our knowledge, this is the first study to apply SEM to address the potential mechanisms
as they evolve in acute dengue illnesses and to build predictive models based on clinical and
laboratory data at various time points in the illness. Another strength of this study is that cau-
sality may be better ascertained through the prospective longitudinal study design. Further,
our predictive models were developed based on easily obtained laboratory data and predictive
performance of the models were evaluated over a variety of time criteria. Inclusion of biomark-
ers could further efforts to discern the mechanisms of disease. While we focused on acute den-
gue illnesses, our approach is likely to be generalizable to other acute illnesses.
Our study does have several limitations. First, in model development, selection bias might
have arisen from the use of data on only 257 of 1,384 participants. Second, the model fit for
DSS was borderline. DSS was a rare event (3.5%), and this likely resulted in instability of the
SEM model. Third, PPVs in some DSS models were low, but this may also be attributed to the
low prevalence of DSS [34]. Fourth, our predictive models were derived from Thai children,
which may limit our ability to generalize these findings to patients in other areas.
In conclusion, our findings highlight the importance of AST and platelet count early in ill-
ness as indicators of dengue, DHF, and DSS. We also identified other early clinical indicators
which can be used to predict outcomes. Our approach may serve as a methodological template
to investigate the mechanisms of other illnesses using SEM.
A structural equation model for dengue
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006799 October 1, 2018 11 / 14
Supporting information
S1 Supporting Information. Additional detail on statistical analysis.
(DOCX)
S2 Supporting Information. Pearson’s correlations.
(DOCX)
S3 Supporting Information. Intercepts and coefficients in SEMs.
(DOCX)
S4 Supporting Information. Additional detail on results.
(DOCX)
S5 Supporting Information. Data.
(XLSX)
Acknowledgments
We are grateful to the children who were involved in the study, as well as their families; the
study staff members who were involved in the collection and processing of specimens.
Author Contributions
Conceptualization: Sangshin Park, Anon Srikiatkhachorn, Sharone Green, Jennifer F. Fried-
man, Alan L. Rothman.
Data curation: Sangshin Park, Anon Srikiatkhachorn, Alan L. Rothman.
Formal analysis: Sangshin Park.
Funding acquisition: Louis Macareo, Alan L. Rothman.
Investigation: Anon Srikiatkhachorn, Siripen Kalayanarooj, Louis Macareo, Sharone Green.
Methodology: Sangshin Park, Anon Srikiatkhachorn, Jennifer F. Friedman, Alan L. Rothman.
Project administration: Alan L. Rothman.
Resources: Siripen Kalayanarooj, Louis Macareo, Alan L. Rothman.
Software: Sangshin Park.
Supervision: Jennifer F. Friedman, Alan L. Rothman.
Validation: Sangshin Park.
Visualization: Sangshin Park.
Writing – original draft: Sangshin Park, Anon Srikiatkhachorn.
Writing – review & editing: Sangshin Park, Anon Srikiatkhachorn, Siripen Kalayanarooj,
Louis Macareo, Sharone Green, Jennifer F. Friedman, Alan L. Rothman.
References
1. World Health Organization. Global strategy for dengue prevention and control 2012–2020. 2012.
2. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and
burden of dengue. Nature. 2013; 496(7446):504–7. Epub 2013/04/09. https://doi.org/10.1038/
nature12060 PMID: 23563266; PubMed Central PMCID: PMCPMC3651993.
A structural equation model for dengue
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006799 October 1, 2018 12 / 14
3. Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a sys-
tematic analysis. Lancet Infect Dis. 2016; 16(8):935–41. https://doi.org/10.1016/S1473-3099(16)
00146-8 PMID: 27091092.
4. Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden
of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016; 16
(6):712–23. https://doi.org/10.1016/S1473-3099(16)00026-8 PMID: 26874619; PubMed Central
PMCID: PMC5012511.
5. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment and control: World Health
Organization; 1997 [1 November 2016]. Available from: http://www.who.int/csr/resources/publications/
dengue/Denguepublication/en/.
6. Guzman MG, Harris E. Dengue. Lancet. 2015; 385(9966):453–65. https://doi.org/10.1016/S0140-6736
(14)60572-9 PMID: 25230594.
7. Potts JA, Thomas SJ, Srikiatkhachorn A, Supradish PO, Li W, Nisalak A, et al. Classification of dengue
illness based on readily available laboratory data. Am J Trop Med Hyg. 2010; 83(4):781–8. https://doi.
org/10.4269/ajtmh.2010.10-0135 PMID: 20889865; PubMed Central PMCID: PMCPMC2946742.
8. Potts JA, Gibbons RV, Rothman AL, Srikiatkhachorn A, Thomas SJ, Supradish PO, et al. Prediction of
dengue disease severity among pediatric Thai patients using early clinical laboratory indicators. PLoS
Negl Trop Dis. 2010; 4(8):e769. https://doi.org/10.1371/journal.pntd.0000769 PMID: 20689812;
PubMed Central PMCID: PMCPMC2914746.
9. Chadwick D, Arch B, Wilder-Smith A, Paton N. Distinguishing dengue fever from other infections on the
basis of simple clinical and laboratory features: application of logistic regression analysis. J Clin Virol.
2006; 35(2):147–53. https://doi.org/10.1016/j.jcv.2005.06.002 PMID: 16055371.
10. Brasier AR, Ju H, Garcia J, Spratt HM, Victor SS, Forshey BM, et al. A three-component biomarker
panel for prediction of dengue hemorrhagic fever. Am J Trop Med Hyg. 2012; 86(2):341–8. https://doi.
org/10.4269/ajtmh.2012.11-0469 PMID: 22302872; PubMed Central PMCID: PMCPMC3269290.
11. Lee IK, Liu JW, Chen YH, Chen YC, Tsai CY, Huang SY, et al. Development of a Simple Clinical Risk
Score for Early Prediction of Severe Dengue in Adult Patients. PloS one. 2016; 11(5):e0154772. https://
doi.org/10.1371/journal.pone.0154772 PMID: 27138448; PubMed Central PMCID: PMC4854400.
12. Nguyen MT, Ho TN, Nguyen VV, Nguyen TH, Ha MT, Ta VT, et al. An evidence-based algorithm for
early prognosis of severe dengue in the outpatient setting. Clin Infect Dis. 2017; 64(5):656–63. https://
doi.org/10.1093/cid/ciw863 PMID: 28034883.
13. Tanner L, Schreiber M, Low JG, Ong A, Tolfvenstam T, Lai YL, et al. Decision tree algorithms predict
the diagnosis and outcome of dengue fever in the early phase of illness. PLoS Negl Trop Dis. 2008; 2
(3):e196. https://doi.org/10.1371/journal.pntd.0000196 PMID: 18335069; PubMed Central PMCID:
PMC2263124.
14. Bentler PM, Stein JA. Structural equation models in medical research. Stat Methods Med Res. 1992; 1
(2):159–81. Epub 1992/01/01. https://doi.org/10.1177/096228029200100203 PMID: 1341656.
15. Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N, et al. Early clini-
cal and laboratory indicators of acute dengue illness. J Infect Dis. 1997; 176(2):313–21. PMID:
9237695.
16. Kim KH. The relation among fit indexes, power, and sample size in structural equation modeling. Struct
Equ Modeling. 2005; 12(3):368–90. https://doi.org/10.1207/s15328007sem1203_2
17. Gnambs T. Required sample size and power for SEM [9 June 2018]. Available from: http://timo.
gnambs.at/en/scripts/powerforsem.
18. Hooper D, Coughlan J, Mullen M. Structural equation modelling: Guidelines for determining model fit.
EJBRM. 2008; 6(1):53–60.
19. Bentler PM, Bonett DG. Significance tests and goodness of fit in the analysis of covariance structures.
Psychological bulletin. 1980; 88(3):588.
20. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. Liver biochemical tests and dengue
fever. Am J Trop Med Hyg. 1992; 47(3):265–70. PMID: 1355950.
21. Wang XJ, Wei HX, Jiang SC, He C, Xu XJ, Peng HJ. Evaluation of aminotransferase abnormality in
dengue patients: A meta analysis. Acta tropica. 2016; 156:130–6. https://doi.org/10.1016/j.actatropica.
2015.12.013 PMID: 26739659.
22. Lam PK, Ngoc TV, Thu Thuy TT, Hong Van NT, Nhu Thuy TT, Hoai Tam DT, et al. The value of daily
platelet counts for predicting dengue shock syndrome: Results from a prospective observational study
of 2301 Vietnamese children with dengue. PLoS Negl Trop Dis. 2017; 11(4):e0005498. https://doi.org/
10.1371/journal.pntd.0005498 PMID: 28448490.
23. Huy NT, Van Giang T, Thuy DH, Kikuchi M, Hien TT, Zamora J, et al. Factors associated with dengue
shock syndrome: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013; 7(9):e2412.
A structural equation model for dengue
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006799 October 1, 2018 13 / 14
https://doi.org/10.1371/journal.pntd.0002412 PMID: 24086778; PubMed Central PMCID:
PMCPMC3784477.
24. Aursnes I. Increased permeability of capillaries to protein during thrombocytopenia. An experimental
study in the rabbit. Microvasc Res. 1974; 7(3):283–95. PMID: 4855533.
25. Kitchens CS, Weiss L. Ultrastructural changes of endothelium associated with thrombocytopenia.
Blood. 1975; 46(4):567–78. PMID: 1174690.
26. Kitchens CS, Pendergast JF. Human thrombocytopenia is associated with structural abnormalities of
the endothelium that are ameliorated by glucocorticosteroid administration. Blood. 1986; 67(1):203–6.
PMID: 3940548.
27. Gamble J, Bethell D, Day NP, Loc PP, Phu NH, Gartside IB, et al. Age-related changes in microvascular
permeability: a significant factor in the susceptibility of children to shock? Clin Sci (Lond). 2000; 98
(2):211–6. PMID: 10657278.
28. Lovera D, Martinez de Cuellar C, Araya S, Amarilla S, Gonzalez N, Aguiar C, et al. Clinical Characteris-
tics and Risk Factors of Dengue Shock Syndrome in Children. Pediatr Infect Dis J. 2016; 35(12):1294–
9. https://doi.org/10.1097/INF.0000000000001308 PMID: 27455442.
29. Azin FR, Goncalves RP, Pitombeira MH, Lima DM, Branco IC. Dengue: profile of hematological and bio-
chemical dynamics. Rev Bras Hematol Hemoter. 2012; 34(1):36–41. https://doi.org/10.5581/1516-
8484.20120012 PMID: 23049382; PubMed Central PMCID: PMCPMC3459605.
30. La Russa VF, Innis BL. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin
Haematol. 1995; 8(1):249–70. PMID: 7663049.
31. Furlan NB, Tukasan C, Estofolete CF, Nogueira ML, da Silva NS. Low sensitivity of the tourniquet test
for differential diagnosis of dengue: an analysis of 28,000 trials in patients. BMC Infect Dis. 2016; 16
(1):627. https://doi.org/10.1186/s12879-016-1947-7 PMID: 27809813; PubMed Central PMCID:
PMC5095934.
32. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, et al. Differing influences of
virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect
Dis. 2002; 185(9):1213–21. Epub 2002/05/10. https://doi.org/10.1086/340365 PMID: 12001037.
33. World Health Organization. Dengue guidelines for diagnosis, treatment, prevention and control: new
edition 2009 [30 April 2017]. Available from: http://www.who.int/tdr/publications/documents/dengue-
diagnosis.pdf.
34. Dohoo I, Martin S, Stryhn H. Veterinary Epidemiologic Research.: VER Inc; 2009.
A structural equation model for dengue
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006799 October 1, 2018 14 / 14
